Skip to main content
VCbacked
Log inGet Started

Polyamyna

St. John's, Canada

Polyamyna develops advanced antimicrobial technologies to combat multi-extensive and pan-drug-resistant pathogenic microorganisms.

$354K raised
Sep 2023
Venture - Series Unknown
BiotechnologyLife ScienceNanotechnology

Top Investors

Government of Newfoundland and LabradorGenesisNational Research Council of Canada Industrial Research Assistance ProgramSustainable Development Technology Canada

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Polyamyna

How much funding has Polyamyna raised?
Polyamyna has raised $354K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.
Who are Polyamyna's investors?
Polyamyna's investors include Government of Newfoundland and Labrador, Genesis, National Research Council of Canada Industrial Research Assistance Program, Sustainable Development Technology Canada.
Where is Polyamyna headquartered?
Polyamyna is headquartered in St. John's, Canada.
What does Polyamyna do?
Polyamyna develops advanced antimicrobial technologies to combat multi-extensive and pan-drug-resistant pathogenic microorganisms.
What stage is Polyamyna at?
Polyamyna is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Polyamyna — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/polyamyna. Accessed July 2, 2026.
APA
VCBacked. (2023). Polyamyna — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/polyamyna
Wikipedia (cite web)
{{cite web |title=Polyamyna — Funding & Investors |url=https://www.vcbacked.co/company/polyamyna |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K